Mindset Pharma Inc.
MSSTF · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $2 | $3 | $2 | $2 |
| % Growth | -24.5% | 45.4% | 4.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $3 | $2 | $2 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $3 | $4 | $1 | $1 |
| G&A Expenses | $2 | $1 | $1 | $1 |
| SG&A Expenses | $2 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $5 | $5 | $2 | $2 |
| Operating Income | -$3 | -$2 | -$1 | -$1 |
| % Margin | -156% | -83.5% | -30.1% | -34% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$3 | -$2 | -$1 | -$1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$2 | -$1 | -$1 |
| % Margin | -156% | -83.5% | -30.1% | -34% |
| EPS | -0.03 | -0.022 | -0.006 | -0.006 |
| % Growth | -35.6% | -298.2% | 11.3% | – |
| EPS Diluted | -0.03 | -0.022 | -0.006 | -0.006 |
| Weighted Avg Shares Out | 99 | 95 | 95 | 90 |
| Weighted Avg Shares Out Dil | 99 | 95 | 95 | 90 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$2 | -$1 | -$1 |
| % Margin | -155.4% | -83.1% | -29.5% | -33.2% |